Cargando…

Peripheral effector memory regulatory T cells are incremented and functionally enhanced in successful mite monomeric allergoid sublingual immunotherapy

Detalles Bibliográficos
Autores principales:	Petrarca, Claudia, Lanuti, Paola, Petrosino, Marianna Immacolata, Di Pillo, Sabrina, Mistrello, Gianni, Compalati, Enrico, Otzuki, Takemi, Marchisio, Marco, Pierdomenico, Laura, Paganelli, Roberto, Di Gioacchino, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359259/ https://www.ncbi.nlm.nih.gov/pubmed/33284458 http://dx.doi.org/10.1111/all.14692

Ejemplares similares

The relative clinical impact of sublingual immunotherapy with carbamylated monomeric allergoids on allergic respiratory symptoms
por: Compalati, Enrico, et al.
Publicado: (2015)

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients
por: Hüser, C., et al.
Publicado: (2016)

Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study
por: Di Gioacchino, Mario, et al.
Publicado: (2022)

Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite
por: Compalati, Enrico, et al.
Publicado: (2015)

11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
por: Compalati, Enrico, et al.
Publicado: (2012)

Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice
por: Petrarca, Claudia, et al.
Publicado: (2016)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis
por: Shershakova, Nadezda, et al.
Publicado: (2015)

Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
por: Mösges, Ralph, et al.
Publicado: (2021)

A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy
por: Roger, Albert, et al.
Publicado: (2014)

Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice
por: Soria, I., et al.
Publicado: (2018)

Biological clocks: their relevance to immune-allergic diseases
por: Paganelli, Roberto, et al.
Publicado: (2018)

Sublingual immunotherapy for pediatric patients with mite allergies
por: Kajiume, Teruyuki
Publicado: (2022)

Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper
por: Passalacqua, Giovanni, et al.
Publicado: (2010)

487 Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites
por: Alvarez, Mirta, et al.
Publicado: (2012)

Acute systemic reactions to sublingual immunotherapy for house dust mite
por: Janssens, Nicky S., et al.
Publicado: (2020)

A strange rash with “gloves and socks” distribution
por: Scaparrotta, Alessandra, et al.
Publicado: (2015)

A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy
por: Bilancia, Massimo, et al.
Publicado: (2020)

484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012)

200 Efficacy of Mite Sublingual Immunotherapy in 130 Children with Atopic Dermatitis
por: Tang, Jianping
Publicado: (2012)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Satisfaction of allergic patients treated with house dust mite sublingual immunotherapy
por: Aarestrup, Matheus Fonseca, et al.
Publicado: (2021)

Benefit Effect of Sublingual Dust Mite Drops on the Control of Asthma in Children
por: Wang, Li, et al.
Publicado: (2021)

An underestimated cause of chronic cough: The Protracted Bacterial Bronchitis
por: Di Filippo, Paola, et al.
Publicado: (2018)

98 Specific IGE and IGG Binding to Allergoids of Phleum pratense
por: Cases, Barbara, et al.
Publicado: (2012)

Novel vaccines targeting dendritic cells by coupling allergoids to mannan
por: Benito-Villalvilla, Cristina, et al.
Publicado: (2018)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase
por: Chen, Ming, et al.
Publicado: (2022)

Engineered metal based nanoparticles and innate immunity
por: Petrarca, Claudia, et al.
Publicado: (2015)

Pulmonary Outcomes in Children Born Extremely and Very Preterm at 11 Years of Age
por: Di Filippo, Paola, et al.
Publicado: (2021)

Erythema multiforme syndrome associated with acute acquired cytomegalovirus infection
por: Petrosino, Marianna Immacolata, et al.
Publicado: (2016)

Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
por: Bożek, Andrzej, et al.
Publicado: (2017)

Alum‐adjuvanted allergoids induce functional IgE‐blocking antibodies
por: Reithofer, M., et al.
Publicado: (2018)

Proteome analysis of human Wharton's jelly cells during in vitro expansion
por: Angelucci, Stefania, et al.
Publicado: (2010)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy
por: Rossi, Renato E, et al.
Publicado: (2010)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_689a0jc656v9c6tu4m0hv56pb5